S. Draheim

发表

Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI.

N. Roehm, C. Román, J. Fleisch, 1999, The Journal of pharmacology and experimental therapeutics.

Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides.

D. R. Berry, N. Chirgadze, D. Clawson, 1996, Journal of medicinal chemistry.

Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides.

D. R. Berry, N. Chirgadze, D. Clawson, 1996 .

Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality.

D. R. Berry, N. Chirgadze, D. Clawson, 1996, Journal of medicinal chemistry.

Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.

D. R. Berry, N. Chirgadze, D. Clawson, 1996, Journal of medicinal chemistry.

Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.

J. L. Bobbitt, W. Jackson, E. D. Mihelich, 1996, The Journal of pharmacology and experimental therapeutics.

Structure-activity relationship within a series of pyrazolidinone antibacterial agents. 1. Effect of nuclear modification on in vitro activity.

R. Ternansky, S. Draheim, 1993, Journal of Medicinal Chemistry.

Structure-activity relationship within a series of pyrazolidinone antibacterial agents. 2. Effect of side-chain modification on in vitro activity and pharmacokinetic parameters.

A. Pike, R. Ternansky, F. T. Counter, 1993, Journal of medicinal chemistry.

The chemistry of substituted pyrazolidinones; applications to the synthesis of bicyclic derivatives

R. Ternansky, S. Draheim, 1992 .

Orally absorbable cephalosporin antibiotics. 2. Structure-activity studies of bicyclic glycine derivatives of 7-aminodeacetoxycephalosporanic acid.

D. Hunden, J. Ott, F. T. Counter, 1985, Journal of medicinal chemistry.

Structure‐Activity Relationship within a Series of Pyrazolidinone Antibacterial Agents. Part 1. Effect of Nuclear Modification on in vitro Activity.

R. Ternansky, S. Draheim, 1994 .

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2

J.-P. Wery, D. Clawson, R. Schevitz, 1995, Nature Structural Biology.

[3.3.0] Pyrazolodinones: An efficient synthesis of a new class of synthetic antibacterial agents.

R. Ternansky, S. Draheim, 1990 .

(3.3.0)Pyrazolidinones: An Efficient Synthesis of a New Class of Synthetic Antibacterial Agents.

R. Ternansky, S. Draheim, 1991 .

Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. Part 3. Indole-3-glyoxamides.

D. R. Berry, N. Chirgadze, D. Clawson, 1997 .

Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors.

J. L. Bobbitt, E. D. Mihelich, J. Sharp, 1996, European journal of pharmacology.

[4.3.0] pyrazolidinones as potential antibacterial agents

R. Ternansky, S. Draheim, 1988 .

(4.3.0)-Fused Pyrazolidinones as Potential Antibacterial Agents.

R. Ternansky, S. Draheim, 1989 .

Orally absorbable cephalosporin antibiotics. 1. Structure-activity relationships of benzothienyl- and naphthylglycine derivatives of 7-aminodeacetoxycephalosporanic acid.

R. E. Holmes, S. Draheim, G. Huffman, 1985, Journal of medicinal chemistry.

Orally Absorbable Cephalosporin Antibiotics. Part 1. Structure-Activity Relationships of Benzothienyl- and Naphthylglycine Derivatives of 7-Aminodeacetoxycephalosporanic Acid.

R. E. Holmes, S. Draheim, G. Huffman, 1986 .

Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus.

A. Pike, R. Ternansky, S. Draheim, 1993, Journal of medicinal chemistry.